Document is current
Any future updates will be listed below
-
Authors
Zou, Xinzhi
Palafox, Elizabeth https://orcid.org/0009-0007-3205-9137
Zhao, Cynthia https://orcid.org/0009-0004-3390-2382
Beier, Kevin T. https://orcid.org/0000-0002-4934-1338
Kang, Chil-Yong
Lin, Michael Z. https://orcid.org/0000-0002-0492-1961
-
Funding
Funding for this research was provided by:
Alliance for Cancer Gene Therapy
Damon Runyon Cancer Research Foundation
SU | Stanford Bio-X
SU | Stanford Engineering
U.S. Department of Health & Human Services | National Institutes of Health (DP2AG067666)
Gouvernement du Canada | Canadian Institutes of Health Research (COV-440388)
- License Information
-
More Information
Article History
Received: 20 October 2024
Accepted: 7 May 2026
First Online: 12 June 2026
Competing interests
: X.Z. and M.Z.L. are inventors on a patent application describing the viral constructs in this study. The other authors declare no competing interests.
Free to read: This content has been made available to all.
